{"slideshow_credits": null, "snippet": "Tekmira Pharmaceuticals announced Friday that the trial of TKM-Ebola-Guinea had been stopped because it did not demonstrate a therapeutic benefit.", "abstract": "Tekmira Pharmaceuticals says experimental Ebola drug it has been developing, called TKM-Ebola-Guinea, has not worked on patients in Sierra Leone, dealing setback to what was considered promising new treatment.", "section_name": "Health", "print_page": "3", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK"}, "web_url": "http://www.nytimes.com/2015/06/20/health/clinical-trial-of-experimental-ebola-drug-is-halted.html", "lead_paragraph": "Tekmira Pharmaceuticals announced Friday that the trial of TKM-Ebola-Guinea had been stopped because it did not demonstrate a therapeutic benefit.", "headline": {"main": "Clinical Trial of Experimental Ebola Drug Is Halted", "print_headline": "Setback as Ebola Drug Trial Is Halted"}, "_id": "55844af438f0d873a5d4afdb", "word_count": "427", "multimedia": [], "pub_date": "2015-06-20T00:00:00Z", "source": "The New York Times", "news_desk": "Foreign", "keywords": [{"name": "subject", "value": "Ebola Virus", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "2"}, {"name": "organizations", "value": "Tekmira Pharmaceuticals Corporation", "is_major": "Y", "rank": "3"}, {"name": "glocations", "value": "Sierra Leone", "is_major": "Y", "rank": "4"}, {"name": "subject", "value": "Clinical Trials", "is_major": "N", "rank": "5"}, {"name": "subject", "value": "Medicine and Health", "is_major": "N", "rank": "6"}], "blog": [], "subsection_name": null, "type_of_material": "News"}